V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10465988 | 10070633 | null | null | Palliative (P) | 2022-04-15 | 2022-04-23 | Abiraterone | 02 | N | ABIRATERONE | 101417133 |
| 10466128 | 10070636 | 0 | 83.4 | null | 2019-11-18 | 2020-06-30 | Trial Unspecified | 01 | null | PACLITAXEL | 100100846 |
| 10466910 | 10070640 | 1.74 | 91.1 | null | 2022-03-25 | 2022-04-18 | Capecitabine | 02 | null | CAPECITABINE | 100247733 |
| 10467023 | 10070641 | 1.58 | null | null | null | 2022-05-05 | Abiraterone | 02 | null | ABIRATERONE | 101421103 |
| 10467196 | 10070642 | 1.77 | 79 | 02 | 2021-04-29 | 2021-04-30 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 101503657 |
| 10467460 | 10070647 | 1.68 | 82.5 | null | 2018-03-11 | 2021-01-20 | null | null | null | TRIAL UNSPECIFIED | 100852061 |
| 10467525 | 10070649 | null | 71.4 | 03 | 2016-11-04 | 2016-11-22 | Capecitabine | 02 | N | CAPECITABINE | 101094711 |
| 10467558 | 10070650 | 1.68 | 102.6 | null | 2019-12-20 | 2020-11-09 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | PACLITAXEL | 100755105 |
| 10467595 | 10070651 | 1.8 | null | Palliative (P) | 2020-08-02 | 2020-09-07 | Abiraterone | 02 | N | ABIRATERONE | 100016785 |
| 10467858 | 10070652 | null | null | null | 2017-11-24 | 2021-02-09 | Abiraterone | 02 | null | ABIRATERONE | 100148548 |
| 10467959 | 10070653 | 1.65 | 105.4 | null | 2018-09-16 | 2022-02-11 | Capecitabine | 02 | null | CAPECITABINE | 100780697 |
| 10468119 | 10070654 | null | 96.9 | null | 2022-02-26 | 2022-02-26 | Abiraterone | 02 | null | ABIRATERONE | 101555289 |
| 10468518 | 10070657 | 1.84 | 98.4 | null | 2019-11-15 | 2019-11-15 | null | null | null | PACLITAXEL | 100909344 |
| 10468622 | 10070658 | 1.52 | 0 | Palliative (P) | 2022-02-11 | 2022-02-28 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 101344751 |
| 10468645 | 10070659 | null | 64.2 | null | 2021-11-26 | 2022-03-06 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 100499935 |
| 10468832 | 10070662 | 1.74 | 66 | null | 2020-05-30 | 2020-06-14 | Capecitabine | 02 | null | CAPECITABINE | 101693728 |
| 10468968 | 10070663 | 1.83 | 0 | 03 | null | 2022-01-22 | null | null | N | ABIRATERONE | 100059850 |
| 10469141 | 10070664 | null | 0 | Palliative (P) | 2021-08-08 | 2021-08-08 | null | null | N | HYDROXYCARBAMIDE | 101563653 |
| 10469596 | 10070665 | 1.61 | 81.7 | null | 2019-08-24 | 2019-08-24 | PACLITAXEL | 02 | null | PACLITAXEL | 101357734 |
| 10469838 | 10070667 | 1.66 | 0 | null | 2014-11-03 | 2019-10-31 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 100352601 |
| 10469979 | 10070669 | 1.74 | 73.5 | Adjuvant (A) | 2019-04-30 | 2019-05-05 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 100307280 |
| 10470127 | 10070670 | 1.68 | 0 | Palliative (P) | 2018-01-27 | 2018-02-10 | Avelumab | 02 | N | BENDAMUSTINE + RITUXIMAB | 101514731 |
| 10470307 | 10070671 | 1.57 | 81 | Palliative (P) | 2021-02-11 | 2021-02-22 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101845411 |
| 10470330 | 10070672 | 1.54 | 72 | null | 2021-11-14 | 2021-11-16 | RUXOLITINIB | 02 | null | RUXOLITINIB | 100449604 |
| 10470391 | 10070673 | 1.72 | 94.9 | null | 2021-08-11 | 2021-08-12 | BENDAMUSTINE + RITUXIMAB | 02 | null | BENDAMUSTINE + RITUXIMAB | 101121659 |
| 10470510 | 10070674 | 1.75 | 56 | null | 2019-05-19 | 2019-05-30 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 101300461 |
| 10470927 | 10070675 | 1.72 | 81.5 | null | 2022-03-23 | 2022-04-05 | Avelumab | N | null | DARATUMUMAB | 100582492 |
| 10471092 | 10070677 | 1.57 | 89.7 | null | 2021-11-27 | 2021-12-12 | RUXOLITINIB | 02 | null | RUXOLITINIB | 101576308 |
| 10471114 | 10070678 | 1.65 | 67.4 | 03 | 2022-03-10 | 2022-03-24 | CEMIPLIMAB | 02 | N | RUXOLITINIB | 100512146 |
| 10471236 | 10070679 | 1.61 | 78.6 | Palliative (P) | 2022-02-14 | 2022-03-04 | CEMIPLIMAB | N | N | CEMIPLIMAB | 101540971 |
| 10471287 | 10070680 | 1.58 | 65.5 | Palliative (P) | 2022-03-22 | 2022-04-09 | Venetoclax | 02 | null | VENETOCLAX | 100540689 |
| 10471295 | 10070681 | 1.82 | 91.5 | Adjuvant (A) | 2020-08-10 | 2020-08-25 | RUXOLITINIB | 02 | Y | RUXOLITINIB | 100908442 |
| 10471665 | 10070682 | 1.84 | 67.4 | null | 2020-07-23 | 2021-07-27 | Avelumab | 02 | N | FLUOROURACIL + OXALIPLATIN | 100229875 |
| 10471893 | 10070683 | 1.68 | 0 | Adjuvant (A) | 2019-02-27 | 2019-02-28 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100137080 |
| 10472090 | 10070685 | 0 | 73.5 | Palliative (P) | 2019-01-21 | 2019-02-04 | CEMIPLIMAB | Y | N | CEMIPLIMAB | 100443751 |
| 10472222 | 10070686 | 1.62 | 78.6 | Palliative (P) | 2018-04-20 | 2018-04-27 | Venetoclax | 02 | N | VENETOCLAX | 100440871 |
| 10472268 | 10070687 | 1.68 | 87.6 | null | 2020-10-19 | 2020-11-11 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100556910 |
| 10472299 | 10070688 | 1.71 | 79.9 | Palliative (P) | null | 2020-09-05 | RUXOLITINIB | 02 | N | RUXOLITINIB | 100688783 |
| 10472444 | 10070689 | 1.76 | 77.8 | null | 2021-06-18 | 2021-10-08 | Trastuzumab 21 day loading dose | 02 | null | TRASTUZUMAB | 101525150 |
| 10472593 | 10070690 | null | 65 | null | 2022-04-13 | 2022-04-13 | Avelumab | 02 | N | CARBOPLATIN + GEMCITABINE | 100229655 |
| 10472625 | 10070691 | 1.81 | 82 | null | 2020-08-24 | 2020-08-31 | FLUOROURACIL + OXALIPLATIN | 02 | null | FLUOROURACIL + OXALIPLATIN | 100937102 |
| 10472723 | 10070692 | 1.72 | 0 | Palliative (P) | null | 2017-04-12 | DARATUMUMAB | 02 | N | DARATUMUMAB | 101109091 |
| 10472876 | 10070694 | 1.76 | 54.5 | Palliative (P) | 2018-05-16 | 2018-06-09 | Avelumab | 02 | N | FLUOROURACIL + OXALIPLATIN | 100770190 |
| 10472912 | 10070695 | 1.67 | 45.8 | null | 2022-01-27 | 2022-02-10 | DARATUMUMAB | 02 | null | AVELUMAB | 100389767 |
| 10473000 | 10070696 | 1.73 | 72.6 | Palliative (P) | 2022-03-26 | 2022-04-18 | Avelumab | 02 | N | AVELUMAB | 100170745 |
| 10473086 | 10070697 | 1.59 | 75.4 | Disease modification (D) | 2021-12-04 | 2021-12-18 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 101123983 |
| 10473300 | 10070698 | 1.63 | 96.5 | Palliative (P) | null | 2021-09-27 | Avelumab | N | N | AVELUMAB | 100676385 |
| 10473423 | 10070699 | 1.72 | 62.8 | Adjuvant (A) | 2020-04-27 | 2020-05-18 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 100434608 |
| 10473533 | 10070702 | 1.65 | 87.2 | Adjuvant (A) | 2021-11-04 | 2021-11-04 | Bendamustine+Rituximab(Sub Courses) | 02 | N | BENDAMUSTINE + RITUXIMAB | 100564739 |
| 10473686 | 10070703 | 1.58 | 74.6 | null | 2020-02-29 | 2020-03-13 | DARATUMUMAB | null | null | DARATUMUMAB | 101304954 |